| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02:30 | Cathie Wood's ARK sells BWX Technologies stock, buys GeneDx | ||
| 02:06 | Zebra Technologies partners with Aiva Health for voice AI nurses | ||
| 01:18 | Jonathan Jackson trades in Amazon and O'Reilly Automotive, invests in BP | ||
| 01:18 | Josh Gottheimer's recent trading activity in Microsoft, Air Products, and other companies | ||
| 01:18 | Byron Donalds invests in Netflix and PayPal, sells The Trade Desk shares | ||
| 01:06 | Macquarie cuts Alibaba stock price target on AI investment costs | ||
| 00:54 | WD-40 Q2 FY26 slides show revenue beat, EPS miss on cost pressures | ||
| 00:54 | Morgan Stanley cuts eBay stock price target on Depop acquisition costs | ||
| 00:54 | Wedbush reiterates Palantir stock rating amid Anthropic concerns | ||
| 00:42 | Raymond James cuts Copa Holdings stock price target on fuel costs | ||
| 00:42 | Rithm Capital stock remains BTIG top pick, $16 target reiterated | ||
| 00:30 | Simulations Plus Q2 FY26 slides: margins expand despite mixed growth | ||
| 00:30 | TAP Real Estate names Jeff Jarrard as chief technology officer | ||
| 00:18 | Stifel raises Parker-Hannifin stock price target to $1,000 on survey | ||
| 00:18 | William Blair reiterates Neogen stock rating citing execution improvements | ||
| 00:06 | Freedom Broker lowers Virco Manufacturing stock price target to $7 on weak outlook | ||
| Do | Northwest Natural declares 49.25 cent quarterly dividend | ||
| Do | William Blair reiterates Simply Good Foods stock rating after guidance cut | ||
| Do | Digi Power X amends at-the-market equity offering program | ||
| Do | Raymond James initiates Milestone Pharmaceuticals stock coverage with Strong Buy | ||
| Do | Canaccord reiterates USA Rare Earth stock Buy on Carester deal | ||
| Do | Raymond James initiates Ionis stock with outperform rating | ||
| Do | Raymond James initiates Jazz Pharmaceuticals stock coverage with outperform rating | ||
| Do | Raymond James initiates Praxis Precision Medicines stock coverage with Strong Buy | ||
| Do | Raymond James initiates PTC Therapeutics stock coverage with outperform rating |